GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 39 filers reported holding GENOCEA BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $266,000 | +8.1% | 212,260 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $246,000 | -39.7% | 212,260 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $408,000 | -17.7% | 212,260 | -0.0% | 0.00% | 0.0% |
| Q2 2021 | $496,000 | -12.8% | 212,270 | +1.1% | 0.00% | -50.0% |
| Q1 2021 | $569,000 | +12.0% | 210,060 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $508,000 | +5.6% | 210,060 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $481,000 | +24.3% | 210,060 | +24.7% | 0.00% | 0.0% |
| Q2 2020 | $387,000 | +34.8% | 168,485 | +0.7% | 0.00% | 0.0% |
| Q1 2020 | $287,000 | -15.3% | 167,235 | +1.8% | 0.00% | 0.0% |
| Q4 2019 | $339,000 | -28.6% | 164,235 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $475,000 | -28.7% | 164,235 | -3.2% | 0.00% | -25.0% |
| Q2 2019 | $666,000 | – | 169,735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $878,000 | 2.94% |
| COMMODORE CAPITAL LP | 2,929,447 | $6,855,000 | 2.39% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $462,000 | 0.74% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,615,000 | 0.54% |
| BVF INC/IL | 4,012,404 | $9,389,000 | 0.35% |
| NEA Management Company, LLC | 10,376,936 | $24,282,000 | 0.32% |
| Avoro Capital Advisors LLC | 5,084,184 | $11,897,000 | 0.21% |
| Diametric Capital, LP | 69,977 | $164,000 | 0.12% |
| Boxer Capital, LLC | 1,134,453 | $2,655,000 | 0.09% |
| Ikarian Capital, LLC | 200,000 | $468,000 | 0.04% |